NCT05220709 Bio Impedance Monitoring as a Tool to Assess Fluid Status in the Pediatric Surgical Patient? (PedFluid Study)
| NCT ID | NCT05220709 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Antwerp |
| Condition | Fluid and Electrolyte Imbalance |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-04-05 |
| Primary Completion | 2025-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2022-04-05 with a primary completion date of 2025-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The baseline infusion rate during surgery for pediatric patients still is the 'Holliday and Segar' rule (also known as the 4/2/1 rule) The question arises if this rule is not outdated, since it was calculated based on the caloric need of the pediatric population, calculated for cow milk. The study tends to validate the use of bio impedance measurements for registering fluid shifts in the pediatric surgical patients.
Eligibility Criteria
Inclusion Criteria: * Scheduled for elective surgery or investigation under general anesthesia * Day care or inpatient hospitalisation Exclusion Criteria: * If sedation is needed instead of general anesthesia * Critically ill patients for urgent surgery * Patients who cannot lie still for performing correct measurements on the bio impedance monitor * No informed consent obtained
Contact & Investigator
Vera Saldien, MD,PhD
PRINCIPAL INVESTIGATOR
University Hospital, Antwerp
Frequently Asked Questions
Who can join the NCT05220709 clinical trial?
This trial is open to participants of all sexes, aged 1 Month or older, up to 16 Years, studying Fluid and Electrolyte Imbalance. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05220709 currently recruiting?
Yes, NCT05220709 is actively recruiting participants. Contact the research team at vera.saldien@uza.be for enrollment information.
Where is the NCT05220709 trial being conducted?
This trial is being conducted at Edegem, Belgium.
Who is sponsoring the NCT05220709 clinical trial?
NCT05220709 is sponsored by University Hospital, Antwerp. The principal investigator is Vera Saldien, MD,PhD at University Hospital, Antwerp. The trial plans to enroll 100 participants.